NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP
American Healthcare Reit, Inc. AHR
11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.1B
▲ 11.2% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
$1.00
Payout · FY25
234%
ROE · FY25
2.5%
Net margin · FY25
3.3%
Dividend coverage
0.4×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.1B
Revenue, FY2025 · full 11-year series below
Revenue
Net income
3 cents of every revenue dollar became profit this year.
Per share
—
Diluted EPS, FY2025
EPS
Dividend
Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.
Profitability
2.5%
Return on equity, FY2025
ROE
Operating margin19.8%
Net margin3.3%
Return on assets1.4%
Each USD of equity produced 3 cents of profit this year.
Returned to shareholders
USD 163.5M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 163.5M
Net buybacksUSD -1.2B
Share of profit234.3%
Consecutive raises—
USD 163.5M in dividends — 234% of the year's profit, so the payout drew on cash built up earlier.
Growth
+14.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+14.0%
+14.4%
Net income
+100.3%
EPS, diluted
+53.1%
Dividend / share
−14.5%
+3.1%
Returned to shareholders
+31.6%
+26.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.4B
total assets, end of FY2025
Total assetsUSD 5.4B
EquityUSD 3.3B
CashUSD 114.8M
Gross debtUSD 966.9M
Net debtUSD 852.1M
Net debt stands at 26% of equity.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue $B
2.1
1.9
1.7
1.4
1.1
1.1
1.1
0.0
0.0
0.0
0.0
Operating income $B
0.4
0.4
0.3
0.3
0.2
0.2
0.2
−0.0
0.0
−0.0
0.0
EBITDA $B
0.6
0.5
0.5
0.5
0.3
0.3
0.3
0.0
0.0
−0.0
0.0
Income tax $B
−0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
·
Net income $B
0.1
−0.0
−0.1
−0.1
−0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
EPS, diluted $
·
·
·
·
·
·
·
·
·
·
·
Dividend / sh $
1.00
1.00
1.00
1.60
0.69
0.86
0.65
0.60
0.60
0.40
·
Payout %
234
−320
−107
−63
−48
1248
−1261
−167
1183
−10
·
ROE %
2.5
−2.1
−5.4
−5.5
−3.9
0.3
−0.8
·
0.6
−11.8
0.0
Shares out B
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
21 of 21
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed